Get started
Author

Bryan M. Edwards

Observed names: B Edwards, B. Edwards, Bryan Edwards, Bryan M Edwards
ORCID: 0009-0002-4884-3405
Observed ORCID: 0009-0002-4884-3405
OpenAlex ID: A5003405691
Generation and characterization of LymphoStat‐B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator
2003 · Kevin P. Baker, Bryan M. Edwards, et al. · Arthritis & Rheumatism · 509
HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo
2005 · L Pukac, P Kanakaraj, et al. · British Journal of Cancer · 310
PDF
Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens
2008 · C. Lloyd, D. Lowe, et al. · Protein Engineering Design and Selection · 132
PDF
The Remarkable Flexibility of the Human Antibody Repertoire; Isolation of Over One Thousand Different Antibodies to a Single Protein, BLyS
2003 · Bryan M. Edwards, Steven C. Barash, et al. · Journal of Molecular Biology · 101
Small-Format Drug Conjugates: A Viable Alternative to ADCs for Solid Tumours?
2018 · Mahendra Deonarain, Gokhan Yahioglu, et al. · Antibodies · 94
PDF
Affinity maturation of phage display antibody populations using ribosome display
2006 · Maria Groves, Steven Lane, et al. · Journal of Immunological Methods · 69
Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism
2009 · Claire L. Dobson, Sarah Main, et al. · mAbs · 37
PDF
Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors
2017 · Caroline S. Colley, Bojana Popovic, et al. · mAbs · 34
PDF
Diverse human VH antibody fragments with bio-therapeutic properties from the Crescendo Mouse
2019 · Yumin Teng, Joyce L. Young, et al. · New Biotechnology · 30
PDF
Isolation and tissue profiles of a large panel of phage antibodies binding to the human adipocyte cell surface
2000 · Bryan M Edwards, Sarah H Main, et al. · Journal of Immunological Methods · 28
Evolution of Antibodies In Vitro by Ribosome Display
2012 · Bryan M. Edwards, Mingyue He · Methods in molecular biology · 9
Eukaryotic Ribosome Display with In Situ DNA Recovery
2011 · Mingyue He, Bryan M. Edwards, et al. · Methods in molecular biology · 9
Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al. · Molecular Cancer Therapeutics · 5
Antibody‐Induced Lysis of Isolated Rat Epididymal Adipocytes and Complement Activation In Vivo
2002 · Keith Dickinson, Tracey J. North, et al. · Obesity Research · 4
PDF
Abstract 909: Antibody fragment drug-conjugates (FDCs)-application of ANT-043 and ANT-045 in solid tumors
2021 · Mahendra P. Deonarain, Gokhan Yahioglu, et al. · Cancer Research · 3
Abstract 2901: Gastric cancer antibody fragment drug-conjugates (FDCs): From concept to clinical development
2020 · Mahendra P. Deonarain, Gokhan Yahioglu, et al. · Cancer Research · 2
Abstract 4399: ANT045: A novel format, antibody fragment drug-conjugate (FDC) product for challenging cMET-expressing solid tumors
2026 · Mahendra Deonarain, Bryan Edwards, et al. · Cancer Research
Abstract 2408: ADCs in cancer treatment: SPR-driven insights into discovery and characterization.
2026 · Soraya Diez-Posada, Cynthia Shuman, et al. · Cancer Research
Supplementary Figure 4 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
PDF
Supplementary Data from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
Supplementary Figure 1 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
PDF
Supplementary Figure 9 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
PDF
Supplementary Table 2 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
Supplementary Table 4 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
Supplementary Table 1 from Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs
2025 · Ioanna Stamati, Gokhan Yahioglu, et al.
Works count: 37
Citation count: 1,376
H-index: 10
I10-index: 10
Year
Topic
Type